Phemphunananchai K

References (3)

Title : Repurposing FDA-approved drugs as multi-target neuroprotective agents for Alzheimer's disease via computational screening and experimental validation - Phemphunananchai_2026_Sci.Rep_16_
Author(s) : Phemphunananchai K , Waiwut P , Phetcharaburanin J , Poonsawas P , Boonyarat C
Ref : Sci Rep , 16 : , 2026
Abstract :
PubMedSearch : Phemphunananchai_2026_Sci.Rep_16_
PubMedID: 41946775

Title : Multi-Targeted Anti-Alzheimer's Effects of Tri-Sannibat-Phol: Biological Evaluation, Behavioral Validation, and LC-MS\/MS Phytochemical Profiling - Takomthong_2026_Pharmaceuticals.(Basel)_19_
Author(s) : Takomthong P , Waiwut P , Kongkiatpaiboon S , Phemphunananchai K , Boonyarat C
Ref : Pharmaceuticals (Basel) , 19 : , 2026
Abstract :
PubMedSearch : Takomthong_2026_Pharmaceuticals.(Basel)_19_
PubMedID: 42515744

Title : Phytomedicine Potential of Oroxylum indicum Root and Its Constituents: Targeting Alzheimer's Disease - Summat_2025_Plants.(Basel)_14_
Author(s) : Summat R , Waiwut P , Daodee S , Nualkaew N , Phemphunananchai K , Arsito PN , Chulikhit Y , Montakantirat O , Khamphukdee C , Boonyarat C
Ref : Plants (Basel) , 14 : , 2025
Abstract :
PubMedSearch : Summat_2025_Plants.(Basel)_14_
PubMedID: 39861577